Alec S McCranie, Caitlin Blades, Steven Dawson, Jose A Foppiani, Taylor Allenby, Julian Winocour, Justin Cohen, David Mathes, Christodoulos Kaoutzanis
{"title":"Abdominal Wall Reinforcement Using OviTex after Deep Inferior Epigastric Perforator Flap.","authors":"Alec S McCranie, Caitlin Blades, Steven Dawson, Jose A Foppiani, Taylor Allenby, Julian Winocour, Justin Cohen, David Mathes, Christodoulos Kaoutzanis","doi":"10.1055/a-2555-2348","DOIUrl":null,"url":null,"abstract":"<p><p>Abdominal wall bulges and hernias are not uncommon complications following deep inferior epigastric perforator (DIEP) flap harvest. Abdominal wall reinforcement using synthetic meshes has been found to decrease bulges by up to 70%; however, such meshes can be associated with other issues such as seromas and infections. Reinforced tissue matrix (RTM) mesh can be used for abdominal wall reinforcement due to its ability to recruit fibroblasts and provide a scaffold for cellular proliferation. There is no literature on the use of OviTex mesh for abdominal wall reinforcement following DIEP flap harvest. Therefore, this study aimed to evaluate the efficacy and safety of its use in this setting.A retrospective review was performed on patients undergoing DIEP flap harvest between January 2020 and June 2023. Patients who had completed at least 12 months of follow-up visits were included. Descriptive, univariate, and multiple logistic regression analyses were completed.A total of 199 patients were included. The mean age at the time of surgery was 51.1 ± 10.0 years and the mean body mass index (BMI) was 30.2 ± 5.9 kg/m<sup>2</sup>. Abdominal wall reinforcement was completed in 85 (42.7%) patients. Patients who had OviTex placed developed fewer bulges compared to the non-mesh cohort (0% vs. 5.3%, <i>p</i> = 0.04). Furthermore, OviTex mesh did not increase adverse events and was not significantly different in seroma/hematoma rates when compared to the non-mesh cohort (10.6% vs. 5.3%, <i>p</i> = 0.26).This study demonstrates that OviTex mesh is safe and efficacious in reducing the rate of bulges following DIEP flap harvest without increasing other complications.</p>","PeriodicalId":16949,"journal":{"name":"Journal of reconstructive microsurgery","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of reconstructive microsurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2555-2348","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Abdominal wall bulges and hernias are not uncommon complications following deep inferior epigastric perforator (DIEP) flap harvest. Abdominal wall reinforcement using synthetic meshes has been found to decrease bulges by up to 70%; however, such meshes can be associated with other issues such as seromas and infections. Reinforced tissue matrix (RTM) mesh can be used for abdominal wall reinforcement due to its ability to recruit fibroblasts and provide a scaffold for cellular proliferation. There is no literature on the use of OviTex mesh for abdominal wall reinforcement following DIEP flap harvest. Therefore, this study aimed to evaluate the efficacy and safety of its use in this setting.A retrospective review was performed on patients undergoing DIEP flap harvest between January 2020 and June 2023. Patients who had completed at least 12 months of follow-up visits were included. Descriptive, univariate, and multiple logistic regression analyses were completed.A total of 199 patients were included. The mean age at the time of surgery was 51.1 ± 10.0 years and the mean body mass index (BMI) was 30.2 ± 5.9 kg/m2. Abdominal wall reinforcement was completed in 85 (42.7%) patients. Patients who had OviTex placed developed fewer bulges compared to the non-mesh cohort (0% vs. 5.3%, p = 0.04). Furthermore, OviTex mesh did not increase adverse events and was not significantly different in seroma/hematoma rates when compared to the non-mesh cohort (10.6% vs. 5.3%, p = 0.26).This study demonstrates that OviTex mesh is safe and efficacious in reducing the rate of bulges following DIEP flap harvest without increasing other complications.
背景腹壁隆起和疝是腹下深穿支皮瓣切除术后常见的并发症。使用合成网加固腹壁可以减少高达70%的隆起;然而,这种网状物可能与其他问题有关,如血清肿和感染。增强组织基质(RTM)网状物能够募集成纤维细胞并为细胞增殖提供支架,因此可用于腹壁加固。目前还没有关于使用OviTex网在DIEP皮瓣收获后腹壁加固的文献。因此,本研究旨在评估其在这种情况下使用的有效性和安全性。方法回顾性分析2020年1月~ 2023年6月间行DIEP皮瓣切除术的患者。完成至少12个月随访的患者被纳入研究。完成描述性、单变量和多元逻辑回归分析。结果共纳入199例患者。手术时平均年龄为51.1±10.0岁,平均体重指数为30.2±5.9 kg/m2。85例(42.7%)患者完成腹壁加固。放置OviTex的患者与未放置补片的患者相比,出现的肿块较少(0% vs 5.3%, P=0.04)。此外,OviTex补片没有增加不良事件,与非补片组相比,血清肿/血肿率没有显著差异(10.6% vs 5.3%, P=0.26)。结论OviTex补片安全、有效地降低了DIEP皮瓣摘取后的鼓包率,且不增加其他并发症。
期刊介绍:
The Journal of Reconstructive Microsurgery is a peer-reviewed, indexed journal that provides an international forum for the publication of articles focusing on reconstructive microsurgery and complex reconstructive surgery. The journal was originally established in 1984 for the microsurgical community to publish and share academic papers.
The Journal of Reconstructive Microsurgery provides the latest in original research spanning basic laboratory, translational, and clinical investigations. Review papers cover current topics in complex reconstruction and microsurgery. In addition, special sections discuss new technologies, innovations, materials, and significant problem cases.
The journal welcomes controversial topics, editorial comments, book reviews, and letters to the Editor, in order to complete the balanced spectrum of information available in the Journal of Reconstructive Microsurgery. All articles undergo stringent peer review by international experts in the specialty.